Our business promises all users of the first-class items and the most satisfying post-sale company. We warmly welcome our regular and new prospects to join us for House Water Treatment System, Trimethoprim 738-70-5, Crystal Glue Mold Set, We have now four leading solutions. Our products are most effective sold not only during the Chinese market, but also welcomed during the international industry.
Special Design for Treatment With Chemicals - 2-Deoxy-2,2-difluoro-D-erythro-pentofuranos-1- ulose-3,5 -dibenzoate – JIN DUN Detail:
2-Deoxy-2,2-difluoro-D-erythro-pentofuranos-1- ulose-3,5 -dibenzoate is used as the intermediate of Gemcitabine.
Gemcitabine is a pyrimidine nucleotide analogue, which belongs to anti metabolic anticancer drugs. It can prevent the progress of DNA synthesis in a certain period, that is, S-phase. It has the characteristics of wide anticancer spectrum, unique mechanism of action, low toxicity, no cross resistance with other chemotherapeutic drugs and no superposition of toxicity. Today, gemcitabine has been approved for use in more than 90 countries, becoming the first-line drug for the treatment of non-small cell lung cancer and the “gold standard” for the treatment of pancreatic cancer.
Product detail pictures:
Related Product Guide:
It truly is a great way to improve our merchandise and repair. Our mission should be to create imaginative products to prospects with a excellent knowledge for Special Design for Treatment With Chemicals - 2-Deoxy-2,2-difluoro-D-erythro-pentofuranos-1- ulose-3,5 -dibenzoate – JIN DUN , The product will supply to all over the world, such as: kazakhstan, Paraguay, Colombia, By integrating manufacturing with foreign trade sectors, we can offer total customer solutions by guaranteeing the delivery of right items to the right place at the right time, which is supported by our abundant experiences, powerful production capability, consistent quality, diversified product portfolios and the control of the industry trend as well as our mature before and after sales services. We'd like to share our ideas with you and welcome your comments and questions.